Table 4

Global and peripheral assessments before and at days 14, 42, and 84 after treatment

	Baseline	Day 14	Day 42	Day 84
Global assessments (n=21)
Patient global (0–100)	57 (27–100)	23 (3–52)^4-160	11 (1–45)^4-160	10 (1–73)^4-160
Patient pain (0–100)	70 (23–100)	25 (4–61)^4-160	13 (1–50)^4-160	10 (1–86)^4-160
Doctor global (0–100)	57 (12–79)	23 (5–36)^4-160	11 (1–45)^4-160	10 (5–75)^4-160
ESR^4-151 (mm/1st h)	44 (10–101)	6 (2–30)^4-160	5 (2–38)^4-160	4 (2–68)^4-160
CRP^4-151 (g/l)	0.046 (0.007–0.29)	0.003 (0–0.01)^4-160	0.002 (0–0.017)^4-160	0.006 (0–0.155)^4-160

Peripheral assessments (n=18)
Morning stiffness (minutes)	90 (10–300)	5 (0–150)^4-160	10 (0–150)^4-150	5 (0–60)^4-160
Pain peripheral joints (0–100)	75 (20–99)	27 (1–49)^4-160	10,5 (0–31)^4-160	12 (0–84)^4-160
Tender joint count (0–68)	6 (1–18)	2 (0–11)^4-160	0 (0–7)^4-160	0 (0–5)^4-160
Swollen joint count (0–66)	3.5 (1–12)	1 (0–9)^4-160	0 (0–7)^4-160	0 (0–7)^4-160

Values are given as medians (range).
↵4-150 p⩽0.01;
↵4-160 p⩽0.001 (determined by Wilcoxon signed ranks test compared with baseline).
↵4-151 ESR = erythrocyte sedimentation rate; CRP = C reactive protein.